首页 > 市场调查报告书 > 製药

药物开发人工智能人工智能药物研发

药物发现中的人工智慧市场：按治疗领域、按应用、按地区 - 规模、份额、展望、机会分析，2023-2030 年

市场调查报告书

商品编码

1350333

药物发现中的人工智慧市场：按治疗领域、按应用、按地区 - 规模、份额、展望、机会分析，2023-2030 年

Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, By Application, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月08日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2030 年，人工智慧在药物发现领域的全球市场规模将达到 35.474 亿美元，2023 年至 2030 年的复合年增长率为 5.7%。

报告范围		报告详细资料
基准年	2022	2023 年市场规模	美国：12.667亿美元
过去的资料	2018年至2021年	预测期间	2023-2030
预测 2023-2030 年复合年增长率：	15.80%	2030年价值预测	35.474亿美元

人工智慧（AI）是创造智慧机器，特别是智慧电脑程式的科学和工程。 AI技术几乎可以应用于製药科学的各个方面，包括药物发现、药物开发、药物再利用、药物代谢预测、药物毒性分析、药物生产率提高和临床试验。这些技术统称为 AIDD（药物发现人工智慧）。

市场动态：

市场进入者不断增加的技术进步、产品研究、联合研究、研发协议和其他无机成长策略将在预测期内增加全球人工智慧在药物发现市场的成长，预计这将是主要因素。

例如，2023 年5 月16 日，Google Cloud 在Bio-IT 世界大会上宣布了两款新的人工智慧驱动的Lifestyle 产品，以加速生物技术、製药和上市公司的药物发现和精准医疗。宣布了科学解决方案。标靶和先导物识别套件可帮助研究人员识别胺基酸功能并预测蛋白质结构。 Multiomics Suite 加速基因组数据的发现和解释，并帮助公司设计精准治疗方法。

本研究的主要特点

本报告详细分析了用于药物发现的全球人工智慧市场，并提供了以 2022 年为基准年的预测期（2023-2030 年）的市场规模和平均年增长率 (CAGR%)。。
它也揭示了各个细分市场的潜在收入机会，并为该市场提供了一系列有吸引力的投资建议。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
根据公司亮点、产品组合、主要亮点、财务表现和策略等参数，介绍全球人工智慧药物发现市场的领先公司。
本研究涵盖的主要公司包括 IBM Corporation (Ibm Watson Health)、Exscientia、GNS Healthcare、Alphabet, Inc. (DEEPMIND)、Benevolent AI、Biosymetrics、Euretos、Berg LLC.、Atomwise, Inc. 等。
此报告的见解使行销人员和公司主管能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球药物发现中的人工智慧市场报告针对该行业的各个利益相关者，例如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
透过用于分析全球人工智慧药物发现市场的各种策略矩阵，将有助于利害关係人做出决策。

市场动态
- 降低药物开发和勘探成本的需求日益增加
- 慢性病的增加支持个人化药物的开发
- 医疗保健和药物发现领域大数据和资讯的爆炸性增长
- 拓展人工智慧在医疗健康各领域的应用
影响分析
主要亮点
监管场景
产品发布/核准
PEST分析
波特的分析
合併/收购场景

第 4 章药物发现中的人工智慧市场 - 冠状病毒 (COVID-19) 大流行的影响

COVID-19 的流行病学
供给面与需求面分析
经济影响

第五章药物发现中的人工智慧市场：依治疗领域划分，2023-2030

肿瘤学
神经退化性疾病
心血管疾病
代谢性疾病
传染病
其他

第 6 章药物发现中的人工智慧市场，按应用划分，2020-2030 年

药物优化与再利用
临床前研究
其他

第 7 章药物发现中的人工智慧市场（按地区划分，2023-2030 年）

北美
拉丁美洲
欧洲
亚太地区
中东
非洲

第八章竞争态势

IBM Corporation（Ibm Watson Health）
Exscientia
GNS Healthcare
Alphabet, Inc.（DEEPMIND）
Benevolent AI
Biosymetrics
Euretos
Berg LLC.
Atomwise, Inc.

第 9 章

调查方法
关于出版商

简介目录

Product Code: CMI6125

The global artificial intelligence in drug discovery market was valued at US$ 1,016.1 Mn in 2022 and is forecast to reach a value of US$ 3,547.4 Mn by 2030 at a CAGR of 5.7% between 2023 and 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,266.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	15.80%	2030 Value Projection:	US$ 3,547.4 Mn

Artificial Intelligence in Drug Discovery Market - IMG1

The Artificial intelligence (AI) is the science and engineering of making intelligent machines, especially intelligent computer programs. The AI techniques are also applicable to drug discovery, drug development, drug repurposing, drug metabolism prediction, drug toxicity analysis, improving pharmaceutical productivity, clinical trials and almost all aspects of pharmaceutical sciences. All these techniques are collectively considered under AIDD (Artificial Intelligence in Drug Discovery).

Market Dynamics:

Increasing technological advancements, product launches by market players, collaborations, research and development agreements and other inorganic growth strategies by market players are major factors expected to augment growth of the global artificial intelligence in drug discovery market over the forecast period.

For instance, on May 16 2023, Google Cloud, in Bio-IT World Conference announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence in drug discovery market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial intelligence in drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include IBM Corporation (Ibm Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial intelligence in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in drug discovery market.

Detailed Segmentation:

Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space:
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Infectious Diseases
- Other
Global Artificial Intelligence in Drug Discovery Market, By Application:
- Drug Optimization & Repurposing
- Preclinical Testing
- Others
Global Artificial Intelligence in Drug Discovery Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- IBM Corporation (Ibm Watson Health)
- Exscientia
- GNS Healthcare
- Alphabet, Inc. (DEEPMIND)
- Benevolent AI
- Biosymetrics
- Euretos
- Berg LLC.
- Atomwise, Inc.

Market Dynamics
- Rising need to curb drug development and discovery costs
- Rising prevalence of chronic diseases supporting development of personalized drugs
- Big data and information explosion in healthcare and drug discovery
- Growing applications of AI in various healthcare areas
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Artificial Intelligence in Drug Discovery Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Neurodegenerative Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Metabolic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

6. Artificial Intelligence in Drug Discovery Market, By Application, 2020-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Drug Optimization & Repurposing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Preclinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

7. Artificial Intelligence in Drug Discovery Market, By Geography, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)

8. Competitive Landscape

IBM Corporation (Ibm Watson Health)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exscientia
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GNS Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alphabet, Inc. (DEEPMIND)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Benevolent AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biosymetrics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Euretos
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Berg LLC.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Atomwise, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views